Betamethasone Acetateis a glucocorticoid steroid with anti-inflammatory and immunosuppressive properties.
This report contains market size and forecasts of Betamethasone Acetate API in global, including the following market information:
Global Betamethasone Acetate API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Betamethasone Acetate API Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Betamethasone Acetate API companies in 2021 (%)
The global Betamethasone Acetate API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Betamethasone Acetate API include Teva Pharmaceutical Industries, Anuh Pharma, Pharmaffiliates, Hovione, Jinan Boss Chemical Industry, Zhejiang Xianju Xianle Pharmaceutical and Fengchen Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Betamethasone Acetate API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Betamethasone Acetate API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Betamethasone Acetate API Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Betamethasone Acetate API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Betamethasone Acetate API Market Segment Percentages, by Application, 2021 (%)
Treatment Of Asthma
Treatment Of Itching
Global Betamethasone Acetate API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Betamethasone Acetate API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Betamethasone Acetate API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Betamethasone Acetate API revenues share in global market, 2021 (%)
Key companies Betamethasone Acetate API sales in global market, 2017-2022 (Estimated), (MT)
Key companies Betamethasone Acetate API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical Industries
Anuh Pharma
Pharmaffiliates
Hovione
Jinan Boss Chemical Industry
Zhejiang Xianju Xianle Pharmaceutical
Fengchen Group